Joseph M. Miller is CFO at Aurinia Pharmaceuticals Inc. (AUPH). They have made 8 open-market trades across 2 companies since 2019, most recently 2026-03-02.
CIK 0001746372
3 open-market purchases totalling $21K since 2019, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AUPH | SELL | 2025-03-03 | 2025-03-04 | $7.95 | $1.4M | +0.7% | -0.6% | -1.7% |
| AUPH | SELL | 2024-03-06 | 2024-03-07 | $5.60 | $390K | -5.1% | -8.8% | +0.0% |
| AUPH | SELL | 2023-03-02 | 2023-03-06 | $8.94 | $101K | +3.3% | +7.8% | +7.0% |
| AUPH | SELL | 2023-03-02 | 2024-02-22 | $8.78 | $200K | -6.0% | -16.3% | -7.2% |
| AUPH | SELL | 2022-03-02 | 2022-03-04 | $12.01 | $37K | +2.7% | +15.7% | +2.9% |
| AUPH | BUY | 2021-05-11 | 2021-05-11 | $9.74 | $10K | +18.0% | +14.6% | +42.0% |
| CERC | BUY | 2019-12-10 | 2019-12-11 | $2.85 | $7K | +26.9% | +18.5% | -34.1% |
| CERC | BUY | 2019-06-10 | 2019-06-11 | $2.85 | $3K | -4.0% | +0.8% | -37.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.